LENEXA, Kan., Nov. 9, 2020 /PRNewswire/ -- Today, Clinical
Reference Laboratory (CRL), one of the largest privately held
clinical testing laboratories in the U.S., announced that it has
begun selling its best-in-class CRL Rapid Response™
saliva-based COVID-19 RT-PCR test directly to consumers. At
$110 (which includes the cost of
prepaid FedEx Priority Overnight shipping in both directions), the
easy-to-use, highly accurate test is one of the most affordable
COVID-19 home tests currently available in the market and the
least expensive at-home saliva test.
"Through our ongoing work with organizations and businesses
nationwide, we saw that there was high demand for a reliable,
convenient test that can be self-collected at home," said
Robert Thompson, CRL CEO.
"Individual consumers no longer have to wait in line or make
appointments to get an invasive swab test when they can conduct an
easier saliva-based one right in their own homes."
The CRL Rapid Response™ saliva-based COVID-19 RT-PCR test
is for symptomatic individuals or those who believe they may have
been exposed. The test simply requires that the individual's saliva
be deposited in a collection vial provided and sent to CRL using
the provided prepaid one-day shipping package. Results are
typically available within 24 hours of receipt at the lab and can
be accessed online through a unique two-factor authentication
protected portal—accessible by computer or mobile device. For those
who test positive, Cynergy, a telemedicine provider, will reach out
to provide critical next-step information including the option
to speak with a licensed physician about their results. Prior to
taking the test, individuals will need to give consent for the
telemedicine provider and their local public health departments to
receive the test results.
"People can be confident that CRL gets their results right,
using highly sensitive and accurate RT-PCR testing from a CLIA and
CAP certified laboratory," said Heather
Fehling, PhD, CRL's Chief Scientific Officer, Molecular
Diagnostics. "In our FDA filing, we were able to demonstrate that
CRL Rapid Response™ had the highest sensitivity and
specificity. Our test was at least as accurate as nasopharyngeal
swabs and far more accurate than the shorter anterior nasal swabs,
which are used in most at-home COVID tests."
CRL Rapid Response™ offers convenient self-testing
with better sample collection, protection and transport, combined
with superior testing methodology incorporating technology from
trusted partners Co-Diagnostics and DNA Genotek that ultimately
leads to the most accurate results.
Individual CRL Rapid Response™ tests can be
purchased through the website order.CRLcorp.com. For group
purchases, email covidtesting@crlcorp.com or call 833-
567-8376.
Broadening COVID-19 testing access with CRL Rapid
Response™
Since receiving FDA Emergency Use
Authorization (EUA) in July, CRL has distributed and processed over
150,000 CRL Rapid Response™ tests across multiple
industries including education (K-12 & universities), film
& TV, financial institutions, manufacturers, governments (state
& local) and professional sports, among many others. The test
can be used in virtually any setting, and doesn't use uncomfortable
nasopharyngeal swabs, which require that testing be done by a
health professional in full personal protective equipment (PPE) and
depend on the test taker's technique in order to get accurate
results.
With CRL Rapid Response™, saliva is collected in a DNA
Genotek OMNIgene® ORAL (OM-505) saliva collection
device, specifically designed for self-collection, stabilization,
storage and shipment to the laboratory. Studies conducted by CRL
and DNA Genotek, a subsidiary of OraSure Technologies, Inc.
(NASDAQ: OSUR), demonstrate sample stability of up to
twenty-one days post-collection, enabling at-home collection. CRL
tests the saliva sample by RT-PCR (reverse transcriptome-polymerase
chain reaction) technology, using Patented CoPrimer™ probes and
primers developed by CRL partner Co-Diagnostics Inc. (NASDAQ: CODX)
to detect SARS-CoV-2 (the virus caused by COVID-19) viral RNA with
high sensitivity and specificity.
About Clinical Reference Laboratory
Clinical Reference
Laboratory is one of the largest privately held clinical testing
laboratories in the U.S., performing hundreds of thousands of tests
every day for clients large and small. Our staff of more than 700
associates works around-the-clock to process and report results
seven days a week for many of the largest retail, transportation,
pharmaceutical, healthcare and financial service organizations in
the world. From high-complexity molecular diagnostic COVID-19
testing, to our toxicology and general lab testing, our partners
are as diverse as the testing we perform. Our mission isn't to be
the most recognized laboratory partner, but to be the most trusted
by providing personalized service, accurate testing, rapid
turnaround time, and innovative systems and solutions. Visit us at:
https://www.crlcorp.com or call 833-567-8376 for more
information.
Contact:
Jackie Zygadlo at
CRLmedia@mww.com
View original content to download
multimedia:http://www.prnewswire.com/news-releases/clinical-reference-laboratory-to-market-most-cost-effective-gold-standard-self-collected-covid-19-saliva-test-directly-to-consumers-301168448.html
SOURCE Clinical Reference Laboratory